Sleep Aids (Pharmacies) - Suriname

  • Suriname
  • Revenue in the Sleep Aids market is projected to reach US$30.89k in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.03%, resulting in a market volume of US$32.51k by 2029.
  • In global comparison, most revenue will be generated in the United States (US$1,473.00m in 2024).
  • In relation to total population figures, per person revenues of US$0.05 are generated in 2024.

Key regions: United States, Germany, Australia, India, United Kingdom

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Sleep Aids (Pharmacies) market in Suriname is experiencing significant growth due to several key factors.

Customer preferences:
Suriname has seen an increase in the demand for sleep aids in recent years. This can be attributed to changing lifestyles and the growing awareness of the importance of a good night's sleep. As people become more stressed and busy, they are turning to sleep aids to help them relax and get the rest they need. Additionally, the aging population in Suriname is also contributing to the growth of the sleep aids market, as older individuals often experience difficulty sleeping and may require assistance in falling asleep or staying asleep.

Trends in the market:
One of the major trends in the sleep aids market in Suriname is the shift towards natural and herbal remedies. Consumers are becoming more conscious of the potential side effects of pharmaceutical sleep aids and are seeking alternative options. This has led to an increase in the demand for natural sleep aids, such as herbal teas, essential oils, and supplements. Manufacturers are responding to this trend by introducing a wide range of natural sleep aids to cater to the growing demand. Another trend in the market is the availability of sleep aids over the counter. In Suriname, sleep aids are easily accessible in pharmacies without the need for a prescription. This convenience factor has contributed to the growth of the market, as consumers can purchase sleep aids without the hassle of visiting a doctor. The ease of access has also led to increased awareness and usage of sleep aids among the general population.

Local special circumstances:
Suriname has a diverse population with different cultural backgrounds and traditional practices. This diversity has influenced the sleep aids market, as people from different cultural backgrounds may have unique preferences and beliefs regarding sleep aids. For example, individuals from indigenous communities may prefer traditional herbal remedies for sleep disorders, while those from urban areas may opt for pharmaceutical sleep aids. Additionally, the healthcare system in Suriname plays a role in the sleep aids market. Limited access to specialized sleep clinics and sleep experts may lead individuals to self-diagnose and self-medicate with sleep aids. This can contribute to the demand for sleep aids in pharmacies, as individuals seek quick and accessible solutions to their sleep problems.

Underlying macroeconomic factors:
The growing economy in Suriname has also contributed to the growth of the sleep aids market. As disposable incomes rise, consumers have more purchasing power and are willing to spend on products that improve their quality of life. Sleep aids are seen as a means to improve sleep quality and overall well-being, and consumers are willing to invest in these products. Furthermore, the increasing urbanization and modernization of Suriname have led to changes in lifestyle and sleep patterns. Longer working hours, increased screen time, and higher stress levels are all factors that can negatively impact sleep. As a result, the demand for sleep aids has increased as individuals seek solutions to improve their sleep in a fast-paced and demanding environment. In conclusion, the Sleep Aids (Pharmacies) market in Suriname is experiencing growth due to changing customer preferences, including the shift towards natural remedies, the availability of sleep aids over the counter, and the diverse cultural backgrounds of the population. The macroeconomic factors of a growing economy and changing lifestyles also contribute to the market's development.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)